Class 424/559 - Genitalia (e.g., ovary, uterus, prostate, testis, etc.)

Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the material is or is derived from
No. of patents: 38
Last issue date: 12/18/2007

Number	Title	Issue Date
7309501	Conditioned media to inhibit growth of tumor cells Conditioned media compositions having valuable biological activity are obtained from cultures of immune cells from elasmobranch fishes. A method is provided for producing the conditioned media compositions. Conditioned media obtained using epigonal cells from bonnet...	12/18/2007
7291711	Fluorescent proteins from aquatic species Provided are four new fluorescent proteins. The proteins were derived from two wild-type fluorescent proteins: a red fluorescent protein (RFP) that was isolated from Actinodiscus or Discosoma sp. 1 and a green fluorescent protein (GFP) isolated from	11/06/2007
RE39337	Nude mouse model for human neoplastic disease A nude mouse model for human neoplastic diseases having histologically intact human neoplastic tissue transplanted onto an organ of the mouse which corresponds to the human organ from which the tissue is obtained. ...	10/10/2006
7083807	Pharmaceutical compositions for the controlled release of active substances The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising a) the said at least one active substance, b) between 5 and 60% by weight, r...	08/01/2006
7011700	Antibacterial colorant and ink composition comprising the same The present invention relates to an antibacterial colorant and a composition that includes the antibacterial colorant. The antibacterial colorant has at least one functional group and at least one antibacterial moiety bound thereto by an ester bond or an amide bond....	03/14/2006
6916492	Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses The present invention discloses the process of extraction, purification and characterization of a natural eco-friendly nontoxic cell permeant multiple fluorescent protein dye from a non bioluminescent marine echinoderm Holothuria scabra, compositions containi...	07/12/2005
6908627	Conditioned media for inhibiting growth of tumor cells Conditioned media compositions having valuable biological activity are obtained from cultures of immune cells from elasmobranch fishes. Methods are provided for producing the conditioned media compositions. Conditioned media obtained using epigonal cells from bonnet...	06/21/2005
6689391	Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses The present invention discloses a process of extraction, purification and characterization of a non-polar fluorescent dye from a marine echinoderm Holothuria scabra, compositions containing the dye and various applications of the dye, said dye is a natura...	02/10/2004
6656969	Methods and compositions for inhibiting the proliferation of prostate cancer cells The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of omega-3 fatty acids, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of re...	12/02/2003
6562621	Method of using fish ovarian fluid for culture and preservation of mammalian cells A method of using fish ovarian fluid for culture and preservation of mammalian cells includes obtaining ovarian fluid from a fish, and culturing mammalian cells in media including a commercially defined medium and a nutrient medium, wherein the nutrient m...	05/13/2003
6306823	Purified new epididymal forward motility protein and a process for isolation of the said epididymal forward motility protein useful as a fertility promoter/blocker The subject invention relates to a new forward motility protein isolated from goat epididymal plasma and a process for the isolation of the said epididymal forward motility protein useful as a fertility promoter/blocker comprising subjecting goat epididym...	10/23/2001
6054142	Biocompatible devices with foam scaffolds A biocompatible cell device having an internal foam scaffold to provide a growth surface for encapsulated cells which produce a biologically active molecule....	04/25/2000
5997908	Prostate extract supplemented with zinc A composition of matter comprising crystalline zinc chelated with animal prostate extract provides a convenient source of both fatty acids and zinc for dietary and therapeutic purposes. The pharmaceutical composition is useful for the treatment of diabete...	12/07/1999
5925362	Method to elicit an antitumor response with human prostate-specific antigen Vaccines capable of eliciting an immune antitumor response for prostate tumors are disclosed. The active ingredient in such vaccines is selected from the group consisting of human PSA and expression system capable of generating in situ human PSA....	07/20/1999
5830460	Sertoli cells as transplantation facilitator for cell transplantation A method of producing a sustained localized brain immunosuppressive effect in localized tissues is achieved by transplanting Sertoli cells proximate to the brain tissue....	11/03/1998
5736141	Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant A vaccine for the immunocontraception of mammals is described. The vaccine consists of zona pellucida antigens and an adjuvant encapsulated in a liposome delivery system. The liposome delivery system allows for the slow release of antigen resulting in a p...	04/07/1998
5721348	DNA encoding PH-20 proteins The disclosure relates to isolated DNA encoding all or a portion of a surface protein present in sperm of a mammal. This surface protein of sperm is essential for fertilization in the mammal. Preferably, the sperm surface protein is the PH-20 protein....	02/24/1998
5708157	Secreted proteins and polynucleotides encoding them Novel polynucleotides and the proteins encoded thereby are disclosed....	01/13/1998
5569812	Nude mouse model for human neoplastic disease A nude mouse model for human neoplastic disease having histologically intact human neoplastic tissue transplanted onto an organ of the mouse which corresponds to the human organ from which the tissue is obtained....	10/29/1996
5563059	Use of human inhibin and human activin to increase the number of mature primate oocytes A method is provided for increasing the fertilization potential of oocytes comprising culturing oocytes in vitro with an effective amount of inhibin, activin, or a combination of inhibin and activin. Preferably the oocytes being cultured are immature. Aft...	10/08/1996
5560935	Physiologically active substances extracted from activated tissues The present invention provides a physiologically active substance which inhibits plasma kallikrein production, improves peripheral blood flow, and exhibits analgesic, antiinflammatory and antiallergic action. The physiologically active substance of the pr...	10/01/1996
5484768	Treatment of male infertility by administration of a muellerian inhibiting substance and surgery and/or hormonal treatment A method for the treatment of infertility associated with undescended testes in male animals is disclosed. Also disclosed is a method for effecting testicular germ cell maturation. These methods involve administering to a subject in need of such treatment ...	01/16/1996
5411748	Prostate extract supplemented with zinc A composition of matter comprising zinc and an extract of animal prostatic tissue provides a convenient source of both fatty acids and zinc for dietary and therapeutic purposes. The pharmaceutical composition is useful for the treatment of diabetes. 05411...	05/02/1995
5277917	Ovarian cancer ascites factor, in isolated form Herein described is an ovarian cancer activating factor that has been isolated from ovarian cancer ascites fluid. The factor may be utilized in its isolated form in a screening program aimed at identifying inhibitors of factor-mediated ovarian cancer acti...	01/11/1994
5198216	Performance enhancing compositions of matter, and methods of preparing and utilizing same A composition for enhancing the performance of animals, such as horses or dogs, is composed of adrenal and pituitary raw tissue concentrates, vitamin C, bioflavonoid complex, pantothenic acid, methionine, choline, vitamin B1, vitamin B2, vitamin B6, niaci...	03/30/1993
5102867	Therapeutic treatment of abnormal cell growth with follicle regulatory protein A method of treating a patient exhibiting a neoplasm is provided comprising administering a therapeutically effective dose of Follicle Regulatory Protein (FRP), or a polypeptide analog thereof. The method may be used both pre- and post-operatively....	04/07/1992
5102868	Method for inhibiting follicular maturation A method is provided for inhibiting the maturation of follicles in the ovary of a femal mammal comprising administering to the ovary of the mammal an effective amount of activin. This method is particularly effective in treating polycystic ovarian disease...	04/07/1992
5057497	Oral method for the maintenance of healthy gingival tissues using TRF Absorption of Tissue Respiration Factor (TRF) into the gingival tissues is materially enhanced when it is formulated as a non-astringent hydrophilic pharmaceutical composition containing penetration promoting substances which are both hydrophilic and lipo...	10/15/1991
5057324	Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of kallikrein, thus is useful as drugs such as antiinflammatory, ana...	10/15/1991
5011687	Purified Mullerian inhibiting substance and process for treating human ovarian cancer cells Purified Mullerian inhibiting substance (MIS) is obtained from testicular tissue by extraction, density gradient sedimentation and chromatography. The purified MIS has selective activity for inhibiting the growth of human ovarian cancer cells....	04/30/1991
4996297	Recombinantly expressed rabbit zona pellucida polypeptides The invention relates to antigenic preparations useful for inducing the production of antibodies in an individual which will bind to epitopes on zona pellucida. Also disclosed are immunogenic compositions and methods for immunizing an individual to enable...	02/26/1991
4985254	Method of treating ischemic diseases The present invention relates to physiologically active substances extracted from infected tissues inoculated with a poxvirus. The substances of the present invention have excellent actions to improve blood flow and recover functions of diseased tissues, ...	01/15/1991
4962187	Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same A purified common antigen for colorectal and mucinous ovarian cancer (COTA) is provided which is antigenically distinct from CSAp, CEA and Ca 19-9. The COTA antigen is useful for producing a COTA antibody which is nonreactive with CSAp, CEA or Ca 19-9....	10/09/1990
4784960	Process for preparation of control for use in progesterone receptor A process is disclosed for producing steroid hormone receptor samples to be utilized as controls during assays of various human tissue for steroid hormones, especially estrogen and progesterone. The process comprises collecting tissue known to include suc...	11/15/1988
4749522	Supercritical fluid extraction of animal derived materials Supercritical fluids (SCF) are found to be useful in extracting desired materials from animal tissues, cells, and organs. By varying the choice of SCF, experimental conditions, and animal source material, one may obtain lipids, proteins, nucleotides, sacc...	06/07/1988
4423151	Process for preparation of control for use in estrogen receptor tests A process is disclosed for producing steroid hormone receptor samples to be utilized as controls during assays of various human tissue for steroid hormones, especially estrogen. The process comprises collecting tissue known to include such receptors, addi...	12/27/1983
4314994	Process for obtaining a plasminogen activator The present invention relates to an improved process for the preparation of plasminogen activator. This is a process for separating a plasminogen activator according to U.S. Pat. No. 3,998,947 characterized in that it comprises at least the following stag...	02/09/1982
4083961	Plasminogen activator pharmaceutical compositions The present invention relates to a pharmaceutical composition comprising a plasminogen activator and a polysaccharide sulphate. The invention also covers a process for preparing the pharmaceutical composition and a process for preparing the plasminogen ac...	04/11/1978

PatentStorm

Bizarre Patents

PatentStorm News

Class 424/559 - Genitalia (e.g., ovary, uterus, prostate, testis, etc.)